Abstracts Archive - Page 2507 of 2605 - ACR Meeting Abstracts

Abstract Number: 1423 • 2012 ACR/ARHP Annual Meeting
Vascular Thrombosis and Pregnancy Morbidity in Patients with Systemic Lupus Erythematosus with Positive Antiphospholipid Profile and Thrombocytopenia
Amir Haddad¹, Murray B. Urowitz², Dominique Ibanez² and D. D. Gladman³, ¹Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ²Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada
Background/Purpose: The trigger for a thrombotic in patients with antiphospholipid antibodies is unknown. Thrombocytopenia is among the most common clinical manifestations of the Antiphospholipid antibody…
Abstract Number: 1424 • 2012 ACR/ARHP Annual Meeting
Prevalence and Clinical Significance of Severe Infection in Patients with Systemic Lupus Erythematosus: Preliminary Data From Relesser (Registry of lupus of the Spanish Society of Rheumatology)
José M. Pego-Reigosa¹, Íñigo Rúa-Figueroa², Francisco J. López-Longo³, María Galindo⁴, Jaime Calvo-Alén⁵, Alejandro Olivé⁶, Loreto Horcada⁷, Esther Uriarte⁸, Eva Tomero⁹, Ana Sánchez-Atrio¹⁰, Carlos Montilla¹¹, José Rosas¹², Antonio Fernández-Nebro¹³, Paloma Vela¹⁴, Mercedes Freire¹⁵, Lucía Silva¹⁶, Elvira Díez-Álvarez¹⁷, Carlos Marras¹⁸, Antonio Zea¹⁹, Javier Narváez²⁰, Jose Luis Marenco²¹, Monica Fernández de Castro²², Olaia Fernánde-Berrizbeitia²³, Marian Gantes²⁴ and Celia Erausquin²⁵, ¹Rheumatology, Hospital do Meixoeiro, Vigo, Spain, ²Rheumatology, Hospital Universitario Dr Negrín. Las Palmas, Las Palmas de Gran Canaria, Spain, ³Hospital Gregorio Marañón, Madrid, Spain, ⁴Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain, ⁵Reumatología, Hospital Sierrallana, Torrelavega, Spain, ⁶Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, ⁷Reumatología, Hospital de Navarra, Spain, ⁸Reumatología, Hospital de Donosti, Donosti, Spain, ⁹Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ¹⁰Reumatología, Hospital Príncipe de Asturias, Madrid, Spain, ¹¹Unit Rheumatology, Hospital Universitario de Salamanca, Salamanca, Spain, ¹²Reumatología, Hospital de Marina Baixa, Alicante, Spain, ¹³Reumatología, Hospital Carlos Haya, Malaga, Spain, ¹⁴Reumatología, Hospital General de Alicante, Alicante, Spain, ¹⁵Rheumatology, Hospital Universitario Juan Canalejo, La Coruña, Spain, ¹⁶Rheumatology, Hospital de Guadalajara, Guadalajara, Spain, ¹⁷Reumatología, Hospital de León, León, Spain, ¹⁸Rheumatology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain, ¹⁹Rheumatology, Hospital Universitario Ramon y Cajal, Madrid, Spain, ²⁰Reumatología, Hospital de Bellvitge, Barcelona, Spain, ²¹Rheumatology, Hospital de Valme, Seville, Spain, ²²Hospital Puerta del Hierro, Madrid, Spain, ²³Reumatología, Hospital de Basurto, Basurto, Spain, ²⁴Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain, ²⁵Rheumatology, Hospital de Gran Canaria Dr Negrin, Las Palmas GC, Spain
Background/Purpose: Infection is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). Immunosuppression, comorbidities, and the disease itself makes patients with SLE…
Abstract Number: 1425 • 2012 ACR/ARHP Annual Meeting
Circulating Free Protein S Levels May Be Linked to Cardiovascular Events and Venous Thrombosis in SLE
Gregg J. Silverman¹, John Jung², Ehtisham Akhter³, Michelle Petri⁴ and Caroline Grönwall², ¹Medical and Pathology, NYU School of Medicine, New York, NY, ²NYU School of Medicine, New York, NY, ³Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: SLE patients are at risk for diverse organ systems involvement, which increases the challenges for diagnosis and predictions for the development of specific clinical…
Abstract Number: 1426 • 2012 ACR/ARHP Annual Meeting
The Clinical Relevance of a “False Negative” Enzyme Linked Immunoassay: Which Antinuclear Antibody Screening Test Is Preferred by Rheumatologists in an Integrated Health System?
Rachita Bansal¹, David Bulbin², Alfred E. Denio³, Sandi Kelsey⁴ and Harold Harrison⁴, ¹Dept of Rheumatology, Geisinger Medical Center, Danville, PA, ²Dept of General Internal Medicine, Geisinger Medical Center, Danville, PA, ³Dept of Rheumatology, Geisinger Health System, Danville, PA, ⁴Dept of Pathology, Geisinger Medical Center, Danville, PA
Background/Purpose: Historically, Immunofluorescence Assay (IFA) methodology has been the gold standard for ANA screening. Most clinical laboratories in recent years utilize the Enzyme Linked Immunoassay…
Abstract Number: 1427 • 2012 ACR/ARHP Annual Meeting
Late Onset Systemic Lupus Erythematosus: Is It Actually A Milder Variant?
Juan G. Ovalles-Bonilla¹, Julia Martínez-Barrio¹, Javier Lopez-Longo¹, Inmaculada de la Torre¹, Carlos Gonzalez Fernandez¹, María Montoro Álvarez¹, Francisco Aramburu¹, Carolina Marin¹, Lina Martinez-Estupiñan¹, Juan C. Nieto², Michelle Hinojosa¹, Natalia Bello¹, Indalecio Monteagudo¹ and Luis Carreño¹, ¹Rheumatology, Gregorio Marañón Hospital, Madrid, Spain, ²Pediatria II, Istituto Giannina Gaslini, Genova, Italy
Background/Purpose: Classically, late onset Systemic Lupus Erythematosus (SLE) has been described as a milder variant of the disease. The objective of this study is to…
Abstract Number: 1428 • 2012 ACR/ARHP Annual Meeting
Long-Term Outcomes of Children Born to Women with Systemic Lupus Erythematosus
Evelyne Vinet¹, Mohammed Kaouache², Christian A. Pineau³, Ann E. Clarke⁴, Caroline P. Gordon⁵, Robert W. Platt⁶ and Sasha Bernatsky², ¹McGill University Health Center, Montreal, QC, Canada, ²Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, ³Rheumatology, McGill University Health Centre, Montreal, QC, Canada, ⁴Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, ⁵Rheumatology (East Wing), Medical School, Birmingham, United Kingdom, ⁶McGill University, Montreal, QC, Canada
Background/Purpose: SLE can cause considerable morbidity during pregnancy. Although several studies have evaluated foetal outcome in lupus pregnancy, very few have examined the long-term outcome…
Abstract Number: 1429 • 2012 ACR/ARHP Annual Meeting
Women with Systemic Lupus Erythematosus (SLE) May Have Different Predictors of Risk for Progression of Aorta Calcium (AS) Than Women without SLE
Apinya Lertratanakul¹, Peggy W. Wu², Alan Dyer¹, William Pearce¹, George Kondos³, Daniel Edmundowicz⁴, James Carr⁵ and Rosalind Ramsey-Goldman⁶, ¹Northwestern University, Chicago, IL, ²Rheumatology, Northwestern University, Chicago, IL, ³University of Illinois at Chicago, Chicago, IL, ⁴Temple University School of Medicine, Philadelphia, PA, ⁵Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: Women with SLE have increased rates of subclinical atherosclerosis and cardiovascular (CV) events. We investigated which risk factors may be significant in the rate…
Abstract Number: 1430 • 2012 ACR/ARHP Annual Meeting
Women with Systemic Lupus Erythematosus (SLE) May Have Different Predictors of Risk for Progression of Coronary Artery Calcium (CAC)Than Women without SLE
Apinya Lertratanakul¹, Peggy W. Wu², Alan Dyer¹, William Pearce¹, George Kondos³, Daniel Edmundowicz⁴, James Carr⁵ and Rosalind Ramsey-Goldman⁶, ¹Northwestern University, Chicago, IL, ²Rheumatology, Northwestern University, Chicago, IL, ³University of Illinois at Chicago, Chicago, IL, ⁴Temple University School of Medicine, Philadelphia, PA, ⁵Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: Women with SLE have increased rates of subclinical atherosclerosis and cardiovascular (CV) events. We sought to determine which risk factors may be significant in…
Abstract Number: 1431 • 2012 ACR/ARHP Annual Meeting
Single Photon Emission Computed Tomography Contributes to Clinical Assessments in Neuropsychiatric Systemic Lupus Erythematosus Patients
Maasa Hama¹, Mitsuhiro Takeno¹, Atsushi Ihata¹, Daiga Kishimoto¹, Reikou Watanabe¹, Takeaki Uehara², Ryusuke Yoshimi¹, Yukiko Asami¹, Atsuhisa Ueda¹ and Yoshiaki Ishigatsubo¹, ¹Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, ²Department of Rheumatology, Chigasaki Municipal Hospital, Chigasaki, Japan
Background/Purpose: Because the clinical manifestations of NPSLE are diverse, multifaceted approaches are necessary to evaluate the disease activity and therapeutic responses. We investigated contribution of…
Abstract Number: 1432 • 2012 ACR/ARHP Annual Meeting
Safety and Efficacy of Etanercept in Systemic LUPUS Erythematosus
Josefina Cortes-Hernandez¹, Natalia Egri¹, Miquel Vilardell-Tarres¹ and Josep Ordi-Ros², ¹Medicine Department. Systemic Autoimmune Diseases Unit, Hospital Universitari Vall dxHebron, Institut de Recerca (VHIR),, Barcelona, Spain, ²Internal Medicine, Vall De Hebron General Hospt, Barcelona, Spain
Background/Purpose: TNF is a strong mediator of inflammation with a controversial role in SLE. Whereas few open-label studies have shown efficacy of anti-TNFα agents in…
Abstract Number: 1433 • 2012 ACR/ARHP Annual Meeting
Persistent Dyslipidemia Is a Risk Factor of Progression to Chronic Kidney Disease in Patients with Lupus Nephritis
Dong-Jin Park¹, Kyung-Eun Lee¹, Tae-Jong Kim¹, Yong-Wook Park¹ and Shin-Seok Lee², ¹Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, ²Dept of Int Med/Rheumatology, Chonnam National University Medical School, Gwangju, South Korea
Background/Purpose: To investigate the effect of dyslipidemia at baseline and during follow-up period on the progression to chronic kidney disease (CKD) in patients with biopsy-proven…
Abstract Number: 1434 • 2012 ACR/ARHP Annual Meeting
Cardiovascular Morbidity in a Long-Term Follow-up Cohort of Systemic Lupus Erythematosus Patients in Southern Sweden
Ragnar Ingvarsson¹, Ola Nived², Gunnar Sturfelt³, Anders Bengtsson⁴ and Andreas Jönsen⁵, ¹Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden, ²Department of Clinical Science, Lund University, Rheumatology, Lund, Sweden, ³Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund, Sweden, ⁴Department of Rheumatology, University Hospital Lund, Lund, Sweden, ⁵Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden
Background/Purpose: The main objective was to study the incidence of myocardial infarction in a cohort of patients with Systemic Lupus Erythematosus (SLE) assembled prospectively over…
Abstract Number: 1435 • 2012 ACR/ARHP Annual Meeting
Identifying Systemic Lupus Erythematosus Patients At Higher Risk of Coronary Artery Disease
Dominique Ibanez¹, D. D. Gladman² and Murray B. Urowitz¹, ¹Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada
Background/Purpose: There is a high prevalence of premature atherosclerosis among patients with SLE. The traditional Framingham risk score (FRS) identifies few of the SLE patients…
Abstract Number: 1396 • 2012 ACR/ARHP Annual Meeting
Associates of a History of Thrombosis in Systemic Lupus Erythematosus
Melissa Nastacio¹, Hong Fang², Thomas Kickler², Jayesh Jani², Laurence S. Magder³ and Michelle Petri², ¹Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Johns Hopkins University School of Medicine, Baltimore, MD, ³Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD
Background/Purpose: Thrombosis in SLE is highly associated with antiphospholipid antibodies, yet the majority of those with antiphospholipid antibodies never have a thrombotic event. Plasma microparticles…
Abstract Number: 1397 • 2012 ACR/ARHP Annual Meeting
Risk Factors Associated with Early Central Nervous System Damage Detected Through Perfusion MRI in Patients with Systemic Lupus Erythematosus
Paola Tomietto¹, Federica Casagrande², Maja Ukmar², Luca Weis², Pia Morassi¹, Rita Moretti³, Gianni Biolo³, Carlo Giansante³ and Maria Assunta Cova², ¹Internal Medicine Department, AOU Ospedali Riuniti di Trieste, Trieste, Italy, ²Radiology Department, Radiology Department, University of Trieste, Trieste, Italy, ³Internal Medicine Department, Internal Medicine Department, University of Trieste, Trieste, Italy
Background/Purpose: Antiphospholipid antibodies (aPL), hypertension and accumulated damage (SLICC-DI) have been associated to the severity of cerebral MRI lesions and to cognitive deficits in SLE.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].